Navigation Links
BioMarin Announces Fourth Quarter and Full Year 2010 Financial Results
Date:2/17/2011

tax expense

(1)0.61.1(222.0)(7.0)(227.3) 15 Depreciation3.43.74.24.415.7 24 Amortization0.10.91.01.03.0 4 EBITDA (Loss)6.56.82.5(12.4)3.4 (11) - 1 Stock-based compensation8.59.210.09.837.5 43 Gain on sale of equity investments(0.9)---(0.9) — Contingent consideration

(2)0.70.83.1(0.6)4.0 11 Material non-recurringConvertible debt exchange

(3)---13.713.7 — Acquisition expenses

(4)--1.8-1.8 — Adjusted EBITDA$
4.8$   16.8$
7.4$
.5$
59.5 $43 - $55 (1)  Includes the release of the Company's income tax valuation allowance during 2010.(2)  Represents the changes in the fair value of contingent acquisition consideration payable for the period.   (3)   Represents debt conversion expense associated with the early conversion of a portion our convertible debt in November 2010.(4)   Represents transactions costs associated with the acquisition of ZyStor Therapeutics Inc., during the third quarter of 2010.   Reconciliation of GAAP Net Income (Loss) to EBITDA and Adjusted EBITDAFor the Four Quarters and Fiscal Year 2009(in millions)(unaudited) 2009Three Months EndedYear Ended DecemberNOTESMarch 31June 30September 30December 3131, 2009GAAP Net Income/(Loss)$
(13.1)$
.3$
.6$
4.7$
(0.5)Interest expense, net1.93.51.91.79.0Income tax expense0.40.50.9(0.8)1.0Depreciation2.83.22.43.111.5Amortization1.21.90.20.23.5EBITDA (Loss)(6.8)10.412.08.924.5Stock-based compensation7.89.08.98.834.5Gain on sale of equity investments-(1.6)--(1.6)Material non-recurringUpfront license fees

(1)8.8---8.8Impairment charges

(2)5.9---5.9Adjusted EBITDA$
5.7$   17.8$
20.9$
7.7$
72.1(1)  Represents upfront license payments related to our collaboration agreement with La Jolla Pharmaceutical Company in the first quarter of 2009.   (2)  Includes impairment losses on investments in Summit plc. and La Jolla Pharmaceutical Company recognized during the first quarter
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. BioMarin Initiates Pivotal Phase 3 Trial for GALNS for the Treatment of MPS IVA
2. BioMarin to Host Fourth Quarter and Full Year 2010 Financial Results
3. BioMarin Initiates Phase 1/2 Trial for BMN 701 for the Treatment of Pompe Disease
4. BioMarin Initiates Phase 1/2 Trial for BMN 673 for the Treatment of Genetically-Defined Cancers
5. BioMarin to Present at the J.P. Morgan 29th Annual Healthcare Conference
6. BioMarin to Present at the Deutsche Bank 2010 BioFEST Conference
7. BioMarin Completes Partial Exchange of Convertible Notes Due 2013 for Common Stock
8. BioMarin Announces Third Quarter 2010 Financial Results
9. BioMarin to Host a Research and Development Day on October 19th
10. BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors
11. BioMarin to Present at the UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... July 3, 2015  Obsidian HDS, the developer of ... service for the management of data on pharmaceutical and ... PharmaShine now includes the 2014 Open Payments General and ... on June 30. The data disclosed on Open Payments ... industry and providers totaling $6.49 billion and is the ...
(Date:7/2/2015)... N.C. , July 2, 2015 ... employees to capture critical product and market insights ... many benefits to employee-based studies, it is essential ... their own internal employees to capture critical business-related ... by benchmarking firm, Best Practices, LLC, most benchmarked ...
(Date:7/2/2015)... , July 2, 2015  Fort Lauderdale-based ... pleased to announce that its Consumer Group completed ... to Kerry Group plc (ISE: KRZ) ("Kerry"), one ... and nutrition systems, as well as functional ingredients ... pharmaceutical markets. Farlie Turner served as the exclusive ...
Breaking Medicine Technology:New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine 2Leveraging Employee Insights to Produce Cutting-Edge Market Research 2Farlie Turner's Consumer Group Completes Sale of Insight Beverages to Kerry 2
(Date:7/3/2015)... Los Angeles, CA (PRWEB) , ... July 03, ... ... was opened for enrollment on July 2nd creating a buzz of media ... academy has been published online by HonestyFirstReviews.com's Tiffany Hendricks. , "These days many ...
(Date:7/3/2015)... Kan. (PRWEB) , ... July 03, 2015 , ... ... dedicated exclusively to healthcare providers, has been retained to lead a national ... top-ranked executive search firms in the healthcare industry, B. E. Smith has recently ...
(Date:7/3/2015)... ... July 03, 2015 , ... Jennifer Renee Hanes, DO is the new ... the largest network of independent freestanding emergency rooms in the United States. , “We ... Sienna Plantation facility,” said Executive Medical Director of First Choice Emergency Room, Dr. James ...
(Date:7/3/2015)... ... July 03, 2015 , ... The Celebrity Dresses is currently running ... to those of celebrities will have the opportunity to get 10% discount on orders ... that people do not have to use coupon codes or remember redemption codes. ...
(Date:7/2/2015)... ... July 02, 2015 , ... The American Association of ... the Stop Overdose Stat (S.O.S.) Act of 2015 on June 23, 2015. Together ... seeks to decrease drug overdose – especially of heroin and opioid medication – ...
Breaking Medicine News(10 mins):Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 2Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 3Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 3Health News:Celebrity Fashion Summer Party Dresses on sale at TheCelebrityDresses.com 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 3
... The Program in Women,s Oncology and Breast Health Center ... recently awarded a three-year full accreditation, with commendation, by ... accreditation was awarded after a one-day visit in late ... Center,s clinical facilities, patient charts and the minutes of ...
... 2011 Postoperative adhesions are a major complication in ... hopes of preventing these adhesions by forming a biological ... 2010 issue of the Journal of AAPOS , ... Ophthalmology and Strabismus, a team of researchers from Cairo ...
... By Serena Gordon HealthDay Reporter , SATURDAY, Jan. 1 ... experiences anger toward God at some point in their lives, commonly ... loved one or a trauma. In fact, nearly two out ... to a study in the January issue of the Journal ...
... lung cancer remains to be established, a new study ... of Thoracic Oncology provides compelling evidence of increased ... at China Medical University and Hospital in Taiwan randomly ... Health Insurance (NHI) program. All patients aged 20 years ...
... new study of nursing home records shows more residents ... it longer. The study also estimates that 40 percent ... dementia. Researchers hope the new data will help policymakers ... control Medicare costs. In newly published research analyzing ...
... By Dennis Thompson HealthDay Reporter , THURSDAY, ... played a big role in averting a major health crisis. ... pitch last winter, with public health officials fearing a widespread ... an epidemic was averted, and some health experts believe that,s ...
Cached Medicine News:Health News:Program earns 3-year accreditation with commendation 2Health News:Program earns 3-year accreditation with commendation 3Health News:Use of amniotic membrane may cause complications in strabismus surgery 2Health News:Anger at God Common During Times of Crisis, Study Finds 2Health News:Anger at God Common During Times of Crisis, Study Finds 3Health News:Study finds evidence of increased lung cancer risk among tuberculosis patients 2Health News:Hospice care increasing for nursing home patients with dementia 2Health News:Hospice care increasing for nursing home patients with dementia 3Health News:Hand-Washing May Have Kept Flu at Bay 2Health News:Hand-Washing May Have Kept Flu at Bay 3
... source for a complete line of diagnostic ... all with the quality, reliability and precise ... leader in catheter technology. All of our ... constructed to help minimize the frustration and ...
... EPXT catheter offers an exceptional blend ... for faster, more accurate mapping. Bard's ... levels of tip response and control. ... and long-reach curves provides clinical versatility ...
Sophisticated DecaPolar Catheters provide enhanced recording and mapping quality....
Standard Deflectable Catheters...
Medicine Products: